Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
central nervous system
Biotech
Lilly saves gene therapy biotech with $18M upfront deal
Sangamo can earn up to $1.4 billion in fees and milestones, as well as tiered royalties, if Lilly opts to pursue all five possible targets.
Darren Incorvaia
Apr 3, 2025 6:00pm
Study reveals expanding gene that causes Huntington's disease
Jan 17, 2025 5:00pm
Sanofi inks $400M biobucks deal for Alloy's antisense platform
Jan 8, 2025 5:08am
AbbVie exercises $40M option for Capsida-partnered gene therapy
Jan 7, 2025 10:45am
Novo Holdings-backed SiteOne charges up with $100M financing
Dec 18, 2024 7:00am
UCB-Novartis Parkinson's asset fails to improve symptoms in ph. 2
Dec 16, 2024 3:19pm
